GB0916332D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB0916332D0
GB0916332D0 GBGB0916332.0A GB0916332A GB0916332D0 GB 0916332 D0 GB0916332 D0 GB 0916332D0 GB 0916332 A GB0916332 A GB 0916332A GB 0916332 D0 GB0916332 D0 GB 0916332D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0916332.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0916332.0A priority Critical patent/GB0916332D0/en
Publication of GB0916332D0 publication Critical patent/GB0916332D0/en
Priority to PCT/GB2010/051554 priority patent/WO2011033305A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0916332.0A 2009-09-17 2009-09-17 Medicaments Ceased GB0916332D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0916332.0A GB0916332D0 (en) 2009-09-17 2009-09-17 Medicaments
PCT/GB2010/051554 WO2011033305A1 (en) 2009-09-17 2010-09-16 Mannose 6-phosphate for use in promoting peripheral nerve function after injury

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0916332.0A GB0916332D0 (en) 2009-09-17 2009-09-17 Medicaments

Publications (1)

Publication Number Publication Date
GB0916332D0 true GB0916332D0 (en) 2009-10-28

Family

ID=41277876

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0916332.0A Ceased GB0916332D0 (en) 2009-09-17 2009-09-17 Medicaments

Country Status (2)

Country Link
GB (1) GB0916332D0 (en)
WO (1) WO2011033305A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020033972A1 (en) * 2018-08-10 2020-02-13 New York University Use of mannose 6 phosphate and modifications thereof for memory enhancement and reducing memory impairment
EP4356964A3 (en) 2018-08-10 2024-06-19 New York University Use of igf-2 receptor agonist ligands for treatment of angelman syndrome and autism
CN117679518B (en) * 2022-09-09 2025-11-21 北京达尔文细胞生物科技有限公司 Pharmaceutical composition for preventing and treating convalescence facial paralysis and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516012D0 (en) * 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
US6566339B1 (en) * 1995-08-04 2003-05-20 Renovo Limited Pharmaceutical composition

Also Published As

Publication number Publication date
WO2011033305A1 (en) 2011-03-24

Similar Documents

Publication Publication Date Title
GB0916335D0 (en) Medicaments
DK3023438T3 (en) Anti-gitr-antistoffer
IL217969A (en) Inhaler
GB2467388A8 (en) Inhaler
ZA201108257B (en) Inhaler
AU331057S (en) Inhaler
EP2462514A4 (en) Greenbooks
IL216700A0 (en) Inhaler
DK2464943T3 (en) Systemintegration
GB0915319D0 (en) Combination medicament
GB0914738D0 (en) Inhalers
GB0916332D0 (en) Medicaments
GB2473343B (en) Cable-raceways
GB0922519D0 (en) Inhaler
EP2510125A4 (en) Hyperprimers
GB0903318D0 (en) Medicament
GB0901902D0 (en) Medicament
AU4925P (en) Bonscawi Scaevola aemula
AU4240P (en) Tuckerbox xTriticosecale
AU4924P (en) Bonscablue Scaevola aemula
GB0910772D0 (en) Pharmaceutical
GB201019774D0 (en) Medicaments
GB0903360D0 (en) Concept seven
GB0903335D0 (en) Concept three
GB201206482D0 (en) #magnotherapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)